BioCentury
ARTICLE | Company News

Amdipharm plc, Recordati sales and marketing update

July 20, 2009 7:00 AM UTC

Amdipharm granted Recordati exclusive rights to market TransAct local action transcutaneous (LAT) in Italy and Portugal for symptomatic relief of localized pain involving the musculoskeletal system. T...